The Company had $13.0 million in cash as of December 31, 2007 compared to $10.9 million as of December 31, 2006. The Company's current ratio (current assets divided by current liabilities) was 8 to 1. Stockholders' equity at December 31, 2007 was $37.1 million.
A conference call to review fourth quarter and full year 2007 results
is scheduled for 4:30 p.m. Eastern Time on February 28, 2008. The dial-in
number for the live conference call will be 877-407-8031 (201-689-8031
outside the U.S.). A live webcast of the conference call will be available
on the Company's website, http://www.sdix.com, as well as http://www.vcall.com. For those
who cannot listen to the live broadcast, an audio replay of the call will
be available on each of these websites for 90 days. Telephone replays of
the call will be available from 7:30 p.m. ET on February 28, 2008 through
11:59 p.m. on February 29, 2008. To listen to the telephone replay, dial
877-660-6853 (201- 612-7415 outside the U.S.) and enter account number 286
and conference ID 275460.
Annual Stockholders Meeting
The Company will hold its 2008 Stockholders Meeting on June 17, 2008.
About Strategic Diagnostics Inc.
Strategic Diagnostics Inc. develops, manufactures and markets
biotechnology-based, discovery and detection solutions to a diverse
customer base, across multiple industrial and human health markets. By
applying core competencies and innovative technologies in all aspects of
antigen design, high throughput production and assay development, the
Company produces unique, sophis
|SOURCE Strategic Diagnostics Inc.|
Copyright©2008 PR Newswire.
All rights reserved